SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Tuesday reported a loss of $7 million in its third quarter.
The San Diego-based company said it had a loss of 12 cents per share. Losses, adjusted for asset impairment costs, were 11 cents per share.
The biopharmaceutical company posted revenue of $5.9 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit 92 cents. A year ago, they were trading at $2.62.